AI주식인사이트AI Stock Insight
C

나노엔텍

039860KOSDAQ

53.0 / 100

Reference Date: 2026-10-23

Financial Score16.5 / 40
News Sentiment12.5 / 25
Momentum14.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Rose 8.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

NanoEntek develops, manufactures, and sells in vitro diagnostic medical devices and life science experiment equipment based on the Lab-On-a-Chip (LOC) platform. The company leverages its core Bio-MEMS technology, integrating microfluidics and nanotechnology, to enable applications in cancer diagnostics, cell counting, and other fields. It operates a U.S. sales subsidiary and a B2B healthcare service arm, expanding its global market presence.

Number of Employees

141people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
95.00Industry Average 15.000.0Point

6.3x industry avg (risky)

PBR
1.87Industry Average 1.201.0Point

1.6x industry avg (risky)

ROE
1.92Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
1.76Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲19.3% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲102.6% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 0.3% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (30%)

Current 4,465Won52-week high 7,67052-week low 3,030
1-month return5.0Point

1m +8.51% (rising)

Volume trend6.0Point

Volume surge

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0